Use your IP potential and secure your values with IPrime
Boutique Law Firm for Patent and Trademark Law as well as ICT and Technology Law
The global innovation rhythm is continuously increasing, technology and law are changing ever faster and are shaping the global economic environment in cross-border interaction. This makes the intelligent and strategic handling of intellectual property a challenge - and an indispensable success factor.
IPrime with its two offices in Zürich and Düsseldorf, makes us the comprehensive hub for high-quality European and international IP consulting services.
We represent and support national and international clients in intellectual property matters and in litigation before court. As an IP boutique, where you can count on personal contact persons, we understand the processes and interrelationships in the various industries of our clients in detail. At IPrime, patent attorneys and attorneys at law work closely together - this makes us a highly specialized law firm that develops strategically supported solutions for specialized and also complex topics and cases.
By this approach, we assist start-ups as well as established companies to exploit current and future potential and to secure their values. Competent, distinct and personal.
IPrime Rentsch Kaelin AG | IPrime Legal AG
Hirschengraben 1, 8001 Zürich, Switzerland
IPrime Huhn Sparing Patentanwaltsgesellschaft mbH
Goltsteinstrasse 19, 40211 Düsseldorf, Germany
New Patent Attorney at IPrime
Thomas Kretschmer, European Patent Attorney
IPrime launches new IP China Desk
Specialized advice on intellectual property issues in China, Switzerland and Europe
EU - Japan Economic Partnership Agreement signed
IPrime, CMS und Langmann presented implications of this EU-JP Partnership Agreement in Dusseldorf
New Attorney at Law at IPrime
Ronny D. Banchik, Attorney at Law
New partner firm of IPrime in Düsseldorf, Germany
IPrime expands to Düsseldorf, Germany.
Swiss Federal Tribunal: Disclosure test applicable also for Swiss SPCs
A disclosure test in analogy to CJEU's Medeva decision willl apply for new SPCs in Switzerland